Acrosome 2, 117 Alloplastic Spermatocele Procedures 87

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Cambridge University Press 0521524172 - Sperm Collection and Processing Methods: A Practical Guide Edited by Rajasingam S. Jeyendran Index More information Index acrosome 2, 117 testicular sperm extraction (TESE) 90–6 alloplastic spermatocele procedures 87 transurethral resection of the ejaculatory anejaculation 14, 38, 40, 86–7 ducts (TURED) 58–61 sperm procurement methods 38, 40–9 vasovasostomy 62–75 electrical procedures 43–8 mechanical procedures 40–3 bladder neck reconstruction 32 pharmacological procedures 48–9 bromocriptine, azoospermia treatment 52–3 vs. retrograde flow of semen 30 brompheniramine, retrograde flow of semen antegrade ejaculatory duct canalization and treatment 31 balloon dilation 61–2 cabergoline, azoospermia treatment 53 antisperm antibodies 115, 116 capacitation reaction 6, 107, 117 aspermia 29 in vitro induction 141–2 assisted reproductive technology (ART) 108–9, centrifugation 113–14 141 density gradient centrifugation 129–34 sperm processing procedures 110, 141–53 colloidal silica-based density gradient 130–3 in vitro sperm capacitation induction iodixanol-based density gradient 133–4 141–2 sperm swim-up procedure 125–6 see also specific techniques chymotrypsin treatment 115–16 autonomic dysreflexia 44 coitus interruptus 27 azoospermia 14, 38, 50, 85–6 colloidal silica-based density gradient nonobstructive 50, 51–3, 86 centrifugation 130–3 obstructive 53–84, 85–6 continuous gradient 131 sperm procurement methods 38, 50–84 discontinuous, multiphase gradients 132–3 alloplastic spermatocele procedures 87 column adherence procedure 134–7 antegrade ejaculatory duct canalization and glass wool column filter (GWCF) procedure balloon dilation 61–2 136–7 epididymovasostomy 75–84 Sephadex column filtration procedure 135–6 medical (hormonal) management 51–3 cryopreservation 111, 119–22 microepididymal sperm aspiration (MESA) epididymal sperm 146 88–9 history of 120 percutaneous sperm aspiration (PESA) methodology 121–2 89–90 manual freezing method 122 testicular fine-needle aspiration (TFNA) programmed freezing method 121–2 100–1 specimens with low sperm count or motility testicular microdissection (TMD) 96–9 149–53 157 © Cambridge University Press www.cambridge.org Cambridge University Press 0521524172 - Sperm Collection and Processing Methods: A Practical Guide Edited by Rajasingam S. Jeyendran Index More information 158 Index cryopreservation (cont.) glycerol equilibrium 138–9 testicular sperm 146 gonadotropin-releasing hormone (GnRH), thawing and processing azoospermia semen 137–9 treatment 52 testicular and epididymal sperm 146–8 human chorionic gonadotrophin (hCG), density gradient centrifugation 129–34 azoospermia treatment 51 colloidal silica-based density gradient 130–3 human menopausal gonadotrophin (hMG), iodixanol-based density gradient 133–4 azoospermia donor semen 119, 120, 139 treatment 52 hypogonadism 51–3 ejaculation 12, 13 hypospermia 30 ejaculatory duct obstruction 53–61 diagnosis 54–7 imipramine 49 seminal vesicle aspiration method 56 retrograde flow of semen treatment 31, 32 seminal vesiculography 56–7 impotence 15 sperm count interpretation 57 in vitro fertilization (IVF), sperm processing transrectal ultrasound 55–6 procedures 109, 143 intervention procedures 57–84 intracavernous injections 20–1 antegrade ejaculatory duct canalization and side-effects 21 balloon dilation 61–2 intracytoplasmic sperm injection (ICSI), sperm transurethral resection of the ejaculatory processing ducts (TURED) 58–61 procedures 109, 121, 143–4 electroejaculation 43–8 intrauterine insemination (IUI), sperm processing procedure 45–8 procedures 109, 110, 123–40 risks 44 column adherence procedure 134–7 ephedrine sulfate, retrograde flow of semen density gradient centrifugation method treatment 31 129–34 epididymal blowout 57, 63 semen thawing and processing 137–9 epididymal sperm aspiration 144–5 sperm migration method 124–9 see also microepididymal sperm aspiration iodixanol 133 (MESA) iodixanol-based density gradient centrifugation epididymis 5, 63 133–4 epididymovasostomy 75–84 complications 83 Kallmann’s syndrome 51 preoperative assessment 75–6 procedure 76–82 masturbation 13, 15, 16–18 erection 6, 15 mechanical aid 22–3 procedure 16–17 fertilization 107, 109 home sample procurement 17 see also in vitro fertilization with assistance 18–22 follicle-stimulating hormone (FSH), azoospermia intracavernous injection 20–1 treatment 51–2 oral medication 18–19 subcutaneous injection 21–2 galactose treatment 116 microepididymal sperm aspiration (MESA) 88–9 gamete intrafallopian transfer (GIFT), sperm vs. percutaneous sperm aspiration (PESA) 89 processing minoxidil, intracavernous injection 20 procedures 143 glass wool column filter (GWCF) procedure non-obstructive azoospermia 50, 51–3, 86 136–7 see also azoospermia © Cambridge University Press www.cambridge.org Cambridge University Press 0521524172 - Sperm Collection and Processing Methods: A Practical Guide Edited by Rajasingam S. Jeyendran Index More information 159 Index obstructive azoospermia 53–84, 85–6 see also cryopreservation; retrograde flow of see also azoospermia; ejaculatory duct semen; sperm; sperm procurement obstruction methods orgasm 11 seminal pouch collection method 14, 24–7 laboratory procedure 25–7 papaverine, intracavernous injection 20 gravitational semen removal 25–6 pentoxifylline treatment 116–17 needle aspiration 26–7 percutaneous sperm aspiration (PESA) 89–90 pipetting semen through pouch 26 vs. microepididymal sperm aspiration (MESA) 89 semen aspiration 26 phentolamine, intracavernous injection 20 patient procedure 25 phenylpropanolamine hydrochloride, retrograde seminal vesicle aspiration 56 flow of seminal vesiculography 56–7 semen treatment 31 seminiferous tubules 5 physostigmine, subcutaneous injection 22 Sephadex column filtration procedure 135–6 postcoital voiding insemination 30 sildenafil citrate (Viagra) 18–19 postmortem sperm procurement 102–3 sperm 1 priapism 21 capacitation reaction 6, 107 prostaglandins, intracavernous injection 20 natural filtering 108 prostate gland 5 production rate 4 protein supplementation 112–13 route through female reproductive tract 6 pseudoephridrine hydrochloride, retrograde flow route through male reproductive tract 4–5 of semen volume 2 treatment 31 see also semen psychoactive drugs 49 sperm count cryopreservation of specimens with low sperm rectal probe electrostimulation (RPE) 43–8 count 149–53 procedure 45–8 interpretation 57 risks 44 sperm migration method 124–9 rete testis 5 swim-down procedure 128–9 retrograde flow of semen 14, 28–37 swim-up procedure 124–8, 129 diagnosis 29–30 with centrifugation 125–6 medical treatment 30–2 without centrifugation 126–8 agents 31 sperm motility 6 side-effects 31 cryopreservation of specimens with low sperm postcoital voiding insemination 30 motility 149–53 sperm retrieval from urine 33–7 sperm processing methods 8, 108–9 physiochemical urine modification 33 for assisted reproductive techniques 110, sperm recovery procedures 34–7 141–53 statistics 29 gamete intrafallopian transfer (GIFT) 143 surgical techniques 32 in vitro fertilization 143 vs. anejaculation 30 in vitro sperm capacitation induction 141–2 sample collection see sperm procurement intracytoplasmic sperm injection (ICSI) methods 143–4 semen 11 for intrauterine insemination 110, 123–40 analysis 7 column adherence procedure 134–7 production 11–13 density gradient centrifugation method emission 11–12 129–34 expulsion (ejaculation) 12, 13 semen thawing and processing 137–9 nervous mediation 12–13 sperm migration method 124–9 © Cambridge University Press www.cambridge.org Cambridge University Press 0521524172 - Sperm Collection and Processing Methods: A Practical Guide Edited by Rajasingam S. Jeyendran Index More information 160 Index sperm processing methods (cont.) testicular fine-needle aspiration (TFNA) 91, 100–1 general procedures 109–10, 111–22 TFNA mapping 101–2 sperm washing 111, 112–15 testicular microdissection (TMD) 96–9 treatment procedure 115–19 testicular sperm extraction (TESE) 90–6, 104 see also cryopreservation disadvantage 91–2 sperm procurement methods 1–2, 7–8, 13–14 procedure 92–4 clinical semen collection 14, 38–9 thawing procedure anejaculatory men 38, 40–9 semen 137–9 azoospermic men 38, 50–84 testicular and epididymal sperm 146–8 clinical sperm collection 14, 85–104 transrectal ultrasound (TRUS) 55–6 patient semen collection 13–14, 15–23 transurethral resection of the ejaculatory ducts with assistance 14, 24–37 (TURED) 58–61 postmortem sperm procurement 102–3 tricyclic antidepressants 49 see also specific methods Sperm Select system 127–8 urethra 5 sperm washing 111, 112–15 urine, sperm retrieval from 33–7 centrifugation 113–14 physiochemical urine modification 33 methodology 114–15 sperm recovery procedures 34–7 viscosity reduction 112–13 spermatogenesis 3–4 vacuum tumescence constriction therapy (VTCT) dysfunction 50, 51 22–3 spermatogonia 3–4 side-effects 23 spinal cord injury 41, 44 vaginal drainage 27–8 spousal assistance 24 vas deferens 5 see also seminal pouch collection method vasovasostomy 62–75 subcutaneous injections 21–2 complications 73–4 preoperative assessment 62–4 TEST yolk 117–19 procedures 64–73 media preparation 118–19 Viagra 18–19 methodology 118 vibratory stimulation of the penis 40, 41–3 testicles 2–3, 64 viscosity reduction 112–13 sperm production 4 testicular biopsy sperm extraction 144–6 ZSC II system 127, 128 © Cambridge University Press www.cambridge.org.
Recommended publications
  • Aspermia: a Review of Etiology and Treatment Donghua Xie1,2, Boris Klopukh1,2, Guy M Nehrenz1 and Edward Gheiler1,2*

    Aspermia: a Review of Etiology and Treatment Donghua Xie1,2, Boris Klopukh1,2, Guy M Nehrenz1 and Edward Gheiler1,2*

    ISSN: 2469-5742 Xie et al. Int Arch Urol Complic 2017, 3:023 DOI: 10.23937/2469-5742/1510023 Volume 3 | Issue 1 International Archives of Open Access Urology and Complications REVIEW ARTICLE Aspermia: A Review of Etiology and Treatment Donghua Xie1,2, Boris Klopukh1,2, Guy M Nehrenz1 and Edward Gheiler1,2* 1Nova Southeastern University, Fort Lauderdale, USA 2Urological Research Network, Hialeah, USA *Corresponding author: Edward Gheiler, MD, FACS, Urological Research Network, 2140 W. 68th Street, 200 Hialeah, FL 33016, Tel: 305-822-7227, Fax: 305-827-6333, USA, E-mail: [email protected] and obstructive aspermia. Hormonal levels may be Abstract impaired in case of spermatogenesis alteration, which is Aspermia is the complete lack of semen with ejaculation, not necessary for some cases of aspermia. In a study of which is associated with infertility. Many different causes were reported such as infection, congenital disorder, medication, 126 males with aspermia who underwent genitography retrograde ejaculation, iatrogenic aspemia, and so on. The and biopsy of the testes, a correlation was revealed main treatments based on these etiologies include anti-in- between the blood follitropine content and the degree fection, discontinuing medication, artificial inseminization, in- of spermatogenesis inhibition in testicular aspermia. tracytoplasmic sperm injection (ICSI), in vitro fertilization, and reconstructive surgery. Some outcomes were promising even Testosterone excreted in the urine and circulating in though the case number was limited in most studies. For men blood plasma is reduced by more than three times in whose infertility is linked to genetic conditions, it is very difficult cases of testicular aspermia, while the plasma estradiol to predict the potential effects on their offspring.
  • Brucella Abortus Epididymo-Orchitis Relapsing in the Opposite Testis After Three Months

    Brucella Abortus Epididymo-Orchitis Relapsing in the Opposite Testis After Three Months

    ‹nfeksiyon Dergisi (Turkish Journal of Infection) 2003; 17 (1): 95-98 BRUCELLA ABORTUS EPIDIDYMO-ORCHITIS RELAPSING IN THE OPPOSITE TESTIS AFTER THREE MONTHS ÜÇ AY SONRA KARfiI TEST‹STE TEKRARLAYAN BRUCELLA ABORTUS EP‹D‹D‹MO-ORfi‹T‹ Esragül AKINCI1 Hürrem BODUR1 Çi¤dem ERBAY1 Mehmet DEVEER2 Numune Training and Research Hospital, Ankara 1 Department of Clinical Microbiology and Infectious Diseases 2 Department of Radiology Key Words: Brucellosis, Brucella abortus, orchitis, epididymitis, epididymo-orchitis, relapse Anahtar Sözcükler: Bruselloz, Brucella abortus, orflit, epididimit, epididimo-orflit, relaps SUMMARY Epididymo-orchitis caused by Brucella species is a rare infection. In this article, a 47-year-old man with relaps of Brucella abortus epididymo-orchitis in the opposite testis is presented. Testicular atrophy and aspermia occurred in the patient despite antibiotic therapy. ÖZET Brucella türlerinin neden oldu¤u epididimo-orflit ender görülen bir infeksiyondur. Bu yaz›da, karfl› testisinde tekrarlayan Brucella abortus epididimo-orflitli 47 yafl›nda bir olgu sunulmufltur. Antibiyotik tedavisine karfl›n hastada testis atrofisi ve aspermi geliflmifltir. On physical examination the left hemiscrotum was tender, INTRODUCTION hyperaemic and enlarged greatly. He had a fever of Epididymo-orchitis is a rare manifestation of brucellosis. 38.4¡ C, white blood cell count 17.000/mm3, erythrocyte Brucella species cause granulomatous orchitis usually sedimentation rate 49 mm/h, and CRP 136 mg/l (normal: presenting as an acute or chronic unilateral swelling of <5 mg/l). Urine analysis and liver function tests were the testis (1). Brucellosis is an endemic disease in Turkey. normal. No growth was detected in the ejaculate and In this case report, a patient with Brucella abortus urine cultures.
  • A Complication of Brucellosis: Epididymoorchitis

    A Complication of Brucellosis: Epididymoorchitis

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector International Journal of Infectious Diseases (2006) 10, 171—177 http://intl.elsevierhealth.com/journals/ijid A complication of brucellosis: Epididymoorchitis Esragu¨l Akıncı a,*,Hu¨rrem Bodur a, Mustafa Aydın C¸evik a, Ays¸e Erbay a, Selim Sırrı Eren a,I˙pek Zıraman b, Neriman Balaban c, Ali Atan d,Gu¨lu¨s¸an Ergu¨l e a Department of Infectious Diseases and Clinical Microbiology, Ankara Numune Education and Research Hospital, Ankara, Turkey b Department of Radiology, Ankara Numune Education and Research Hospital, Ankara, Turkey c Department of Microbiology, Ankara Numune Education and Research Hospital, Ankara, Turkey d Department of Urology, Ankara Numune Education and Research Hospital, Ankara, Turkey e Department of Pathology, Ankara Numune Education and Research Hospital, Ankara, Turkey Received 18 October 2004; received in revised form 28 January 2005; accepted 24 February 2005 Corresponding Editor: Marguerite Neill, Pawtucket, USA KEYWORDS Summary Brucellosis; Brucella mellitensis; Background: Epididymoorchitis is the most frequent genitourinary complication of Brucella abortus; brucellosis. Epididymoorchitis; Methods: This prospective study was conducted between February 2001 and January Genitourinary 2004, prospectively. Male patients diagnosed with brucellosis were included in this infections study and evaluated for testicular involvement. Results: Epididymoorchitis was detected in 17 out of 134 (12.7%) male patients with brucellosis. Mean age of the patients was 36.9 Æ 7.1 years. Twelve patients (70.6%) had acute, four patients (23.5%) had subacute, and one patient (5.9%) had chronic brucellosis. The most common symptoms were scrotal pain (94%) and swelling (82%).
  • Infertility in the Male Dog - a Diagnostic Approach [Infertilidade No Cão - Abordagem Clínica]

    Infertility in the Male Dog - a Diagnostic Approach [Infertilidade No Cão - Abordagem Clínica]

    Congresso de Ciências Veterinárias [Proceedings of the Veterinary Sciences Congress, 2002], SPCV, Oeiras, 10-12 Out., pp. 171-176 Animais de Companhia Infertility in the male dog - A diagnostic approach [Infertilidade no cão - Abordagem clínica] Stefano Romagnoli Introduction Infertility in the male dog can which has a normal libido and is able to mount can be due to lack of or incomplete ejaculation or to poor semen quality. Infertility due to inability to mount or to low libido may or may not be a reproductive issue (it is often an orthopedic or a behavioral problem) and will not be discussed here. Ejaculation problems Failure of or incomplete ejaculation may occur if the coital lock is not adequate because of fright or discomfort during mating or at semen collection. Ejaculation may sometimes occur retrogradely into the bladder if there is an incompetence of the internal urethral sphincter muscle Retrograde ejaculation - The ejaculatory process is coordinated by sympathetic and parasympathetic nervous activity, and is divided into seminal emission (the deposition of semen from the vasa deferentia and accessory sex glands into the prostatic urethra) and ejaculation (passage of semen through the uretra and outside through the external urethral orifice). During ejaculation the bladder neck contracts, thus playing an important role in preventing a retrograde flux of spermatozoa into the bladder. Vasa deferentia and bladder neck are primarily under the control of the sympathetic nervous system. Alfa-adrenoceptor stimulation causes contraction of the vas deferens, while beta- adrenoceptor stimulation mediates relaxation of the vas deferens. The use of alfa-adrenergic agonists increases seminal emission: for example, administration of xylazine (alfa-2 adrenoceptor agonist) in the dog causes increased contraction of vasa deferentia and decreased urethral pressure, thereby facilitating passage of spermatozoa into the bladder (not associated to ejaculation).
  • Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part II Peter N

    Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part II Peter N

    Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II Peter N. Schlegel, M.D.,a Mark Sigman, M.D.,b Barbara Collura,c Christopher J. De Jonge, Ph.D, H.C.L.D.(A.B.B.),d Michael L. Eisenberg, M.D.,e Dolores J. Lamb, Ph.D., H.C.L.D.(A.B.B.),f John P. Mulhall, M.D.,g Craig Niederberger, M.D., F.A.C.S.,h Jay I. Sandlow, M.D.,i Rebecca Z. Sokol, M.D., M.P.H.,j Steven D. Spandorfer, M.D.,f Cigdem Tanrikut, M.D., F.A.C.S.,k Jonathan R. Treadwell, Ph.D.,l Jeffrey T. Oristaglio, Ph.D.,l and Armand Zini, M.D.m a New York Presbyterian Hospital-Weill Cornell Medical College; b Brown University; c RESOLVE; d University of Minnesota School of Medicine; e Stanford University School of Medicine; f Weill Cornell Medical College; g Memorial-Sloan Kettering Cancer Center; h Weill Cornell Medicine, University of Illinois-Chicago School of Medicine; i Medical College of Wisconsin; j University of Southern California School of Medicine; k Georgetown University School of Medicine; l ECRI; and m McGill University School of Medicine Purpose: The summary presented herein represents Part II of the two-part series dedicated to the Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. Part II outlines the appropriate management of the male in an infertile couple. Medical therapies, surgical techniques, as well as use of intrauterine insemination (IUI)/in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) are covered to allow for optimal patient management.
  • Infertility & ART Sub Fertility

    Infertility & ART Sub Fertility

    Infertility & ART Sub fertility Dr. Kakali Saha MBBS, FCPS,MS (Obs & Gynae) Associate professor dept. Of Obs & Gynae Medical college for women & hospital Definition • Infertility is defined as the inability of a couple to achieve conception after 1 year of unprotected coitus. • Sub fertility is another commonly used term by infertility specialist. • Sterility is an absolute state of inability to conceive. • Childless is not infertility Frequency of conception • The fecundability of a normal couple has been estimated 20-25% • About 90% of couples conceive after 12 months of regular unprotected intercourse. ✦ 50-60% will conceive in 3 months ✦ 70% will concave in 6 months. Types or classification • Primary infertility -when couple never conceived before • Secondary infertility -when the same states developing after an initial phase of fertility A concept of fertility • Before puberty • After puberty & before maturation • Fertility usually low until the age of 16-17 years • During pregnancy • Dring lactation • After menopause Causes of infertility According to Jeffcoate’s • Female factors - 40% • Male factors - 35% • Combined -10-20% • Unexplained -rest Causes of infertility Now a days observe by infertility specialist • Causes of female factors Male factors • Assessment of male factors Abnormal semen • Aspermia -No semen • Hypospermia -volume <2ml • Hyperspermia - volume >2ml • Azoospermia - no spermatozoa in semen • Oligospermia <20 million sperm/ml • Polyzoospermia - >250 million sperm/ml • Asthenospermia - decrease motility (<25%) • Teratozoospermia - >50% abnormal spermatozoa in semen • Necrospermia - motility 0% ART • Assisted reproductive technology is not new includes medical procedures used primarily to address infertility. This subject involves procedures such as in vitro fertilisation, intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and or use of fertility medications.
  • Reproductive Chances of Men with Azoospermia Due to Spermatogenic Dysfunction

    Reproductive Chances of Men with Azoospermia Due to Spermatogenic Dysfunction

    Journal of Clinical Medicine Review Reproductive Chances of Men with Azoospermia Due to Spermatogenic Dysfunction Caroline Kang † , Nahid Punjani † and Peter N. Schlegel * Department of Urology, Weill Cornell Medical College, New York, NY 10021, USA; [email protected] (C.K.); [email protected] (N.P.) * Correspondence: [email protected] † Equal contribution. Abstract: Non-obstructive azoospermia (NOA), or lack of sperm in the ejaculate due to spermato- genic dysfunction, is the most severe form of infertility. Men with this form of infertility should be evaluated prior to treatment, as there are various underlying etiologies for NOA. While a significant proportion of NOA men have idiopathic spermatogenic dysfunction, known etiologies including ge- netic disorders, hormonal anomalies, structural abnormalities, chemotherapy or radiation treatment, infection and inflammation may substantively affect the prognosis for successful treatment. Despite the underlying etiology for NOA, most of these infertile men are candidates for surgical sperm retrieval and subsequent use in intracytoplasmic sperm injection (ICSI). In this review, we describe common etiologies of NOA and clinical outcomes following surgical sperm retrieval and ICSI. Keywords: non-obstructive azoospermia; infertility; intracytoplasmic sperm injection Citation: Kang, C.; Punjani, N.; 1. Introduction Schlegel, P.N. Reproductive Chances of Men with Azoospermia Due to Infertility affects up to 15% of couples worldwide, with up to 50% of cases attributable Spermatogenic Dysfunction. J. Clin. to male factor infertility [1]. In a majority of cases, the precise etiology underlying infertility Med. 2021, 10, 1400. https://doi.org/ in the male partner remains unclear. A subset of men with infertility have no sperm in 10.3390/jcm10071400 the ejaculate, known as azoospermia, which may further be classified into obstructive (OA) or non-obstructive azoospermia (NOA).
  • Rare Report of Orchitis in a Bull Due to Trypanosoma Evansi Infection

    Rare Report of Orchitis in a Bull Due to Trypanosoma Evansi Infection

    J Parasit Dis (Jan-Mar 2019) 43(1):28–30 https://doi.org/10.1007/s12639-018-1050-7 ORIGINAL ARTICLE Rare report of orchitis in a bull due to Trypanosoma evansi infection 1 2 S. Sivajothi • B. Sudhakara Reddy Received: 14 July 2018 / Accepted: 25 October 2018 / Published online: 10 November 2018 Ó Indian Society for Parasitology 2018 Abstract A 9 years old bull was presented to the hospital clinical signs varies with the type of host and depends on with a history of scrotal swelling for a period of 12 days the host’s immunity and stress levels (Sivajothi and Reddy and progressive emaciation with intermittent fever. Clini- 2018). Commonly reported clinicopathological findings are cal examination revealed the swollen and painful scrotum anaemia, intermittent fever and corneal opacity. In a few with fluid thrill, mild abduction and disorientation of hin- animals, reduction in the working ability and reproductive dlimbs were noticed. Ultrasonography of the testes performance is associated with the reduction in serum revealed the anechoic fluid in between the visceral and thyroxin levels (Reddy et al. 2016). Literature is available parietal layers of tunica vaginalis of testis with variation in on the development of the testicular lesions in T. the echogenicity of the testes. Stained peripheral blood evansi infected experimental animals but, orchitis due to smear examination revealed the presence of Trypanosoma natural T. evansi infected bulls was limited (Shehu et al. evansi organisms. The bull was administered with dimi- 2006). Hence present communication put the record on nazene aceturate, enrofloxacin, flunixin meglumine, mul- orchitis in a bull due to T.
  • Sterility in the Male

    Sterility in the Male

    University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1940 Sterility in the male L. Joe Ruzicka University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Ruzicka, L. Joe, "Sterility in the male" (1940). MD Theses. 828. https://digitalcommons.unmc.edu/mdtheses/828 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. STERILITY IN THE MA.LE Senior Thesis by L. Joe Ruzicka Presented to the College of Medicine, University of Nebraska Omaha, 1940 TABLE OF CONTENTS Introduction ......................................... 1 Definitions .......................................... 2 Incidence •.•••• .. .. .. .. .. .. .. 3 Classification of etiological factors ••••••••...••••• 4 Etiology. 6 Defective production of s pe rma t oz oa • .. .. .. 6 Obstructions or hostilities. .. .. .. .. 14 Faul ts of delivery •••••••••• . .. .. .. 22 D1agn os is . • • . • . • . • . • . • • . • . • • . • . 27 History. 27 Phys 1ca l. • . • • • • . • . • 2t3 Semen appraisal. .. .. .. .. .. .. .. .. 29 Macroscopic. .. .. .. .. .. 33 Microscopic. .. .. .. .. .. 34 Treatment
  • The Optimal Evaluation of the Infertile Male: AUA Best Practice Statement

    The Optimal Evaluation of the Infertile Male: AUA Best Practice Statement

    The Optimal Evaluation of the Infertile Male: AUA Best Practice Statement Panel Members: AUA Staff: Jonathan Jarow, MD, Chairman Heddy Hubbard, PhD, MPH, FAAN, Mark Sigman, MD, Facilitator Cynthia Janus, MLS, Michael Folmer, Kebe Kadiatu Peter N. Kolettis, MD, Larry R. Lipshultz, MD, Consultant: R. Dale McClure, MD, Joan Hurley, JD, MHS Ajay K. Nangia, MD, Cathy Kim Naughton, MD, Gail S. Prins, PhD, Jay I. Sandlow, MD, Peter N. Schlegel, MD Table of Contents Abbreviations and Acronyms ...................................................................................................... 2 Introduction ................................................................................................................................... 3 Methodology .................................................................................................................................. 4 Evaluation goals ............................................................................................................................ 6 When to do a full evaluation for infertility ................................................................................. 7 Components of a full evaluation for male infertility .................................................................. 7 Required evaluation components for every patient ..................................................................... 7 Medical history ------------------------------------------------------------------------------------------ 7 Physical examination -----------------------------------------------------------------------------------
  • Reliability of Testicular Stiffness Quantification Using Shear Wave Elastography in Predicting Male Fertility: a Preliminary Prospective Study

    Original papers Med Ultrason 2018, Vol. 20, no. 2, 141-147 DOI: 10.11152/mu-1278 Reliability of testicular stiffness quantification using shear wave elastography in predicting male fertility: a preliminary prospective study Alpaslan Yavuz1, Adem Yokus1, Kerem Taken2, Abdussamet Batur1, Mesut Ozgokce1, Harun Arslan1 1Department of Radiology, 2Department of Urology, Van Yuzuncu Yil University, Medical Faculty, Van, Turkey Abstract: Aims: To evaluate the reliability of testicular stiffness quantification using shear wave elastography in predicting the fertility potential of males and for the pre-diagnosis of disorders based upon sperm quantification. Material and methods: One hundred males between the ages of 19-49 years (mean age of 28.77±6.11), ninety of whom with complaints of infertility, were enrolled in this prospective study. Scrotal grey-scale, Doppler ultrasound (US), and mean testicular shear wave velocity quantifications (SWVQs) were performed. The volumes of testes, as well as the grade of varicocele if present, were recorded. The mean shear wave velocity values (SWVVs) of each testis and a mean testicular SWVV for each patient were calculated. The semen-analyses of patients were consecutively performed. Results: There were significant negative correlations between the mean testicular SWVVs of patients and their sperm counts or the testis volumes (r=-0.399, r=-0.565; p<0.01, respectively). A positive correlation was found between testicular volumes and sperm counts (r=0.491, p<0.01). The cut-off values regard- ing mean testicular SWVV to distinguish normal sperm count from azoospermia and oligozoospermia were 1.465 m/s (75.0% sensitivity and 75.0% specificity) and 1.328 m/s (64.3% sensitivity and 68.2% specificity), respectively, and the value to distinguish oligozoospermia from azoospermia was 1.528 m/s (66.7% sensitivity, 60.7% specificity).
  • Advisory Committee Industry Briefing Document Testosterone Replacement Therapy

    Testosterone Replacement Therapy Advisory Committee Briefing Document Advisory Committee Industry Briefing Document Testosterone Replacement Therapy Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting on September 17, 2014 Advisory Committee Briefing Materials: Available for Public Release Testosterone Replacement Therapy Advisory Committee Briefing Document Table of Contents 1.0 Executive Summary.................................................................8 2.0 Testosterone Replacement Therapy: Regulatory History ....................................................................................11 2.1 Approval History in the United States .....................................................11 2.2 Requirements for Regulatory Approval...................................................12 2.3 Indication .................................................................................................13 2.4 Safety Labeling ........................................................................................14 2.5 Current Regulatory Activities..................................................................15 3.0 Testosterone, Hypogonadism, Guidelines, and Testosterone Replacement Therapy Benefits .....................16 3.1 Testosterone .............................................................................................16 3.2 Hypogonadism .........................................................................................19 3.2.1 Classification,